How Common Is Losing Sense of Smell Covid
Loss of smell, or anosmia, remains one of the most recognized symptoms of covid-19, reported in a large share of infections across variants. Early in the pandemic, studies found that up to 80 percent of symptomatic patients experienced some degree of smell dysfunction, with many cases linked to the original Wuhan strain and later variants such as Delta. The symptom often appears suddenly and can occur without nasal congestion, distinguishing it from common cold or flu-related smell loss. According to global surveillance data, losing sense of smell covid continues to be a key clinical marker that helps differentiate covid-19 from other respiratory illnesses. For a detailed overview of how covid-19 affects the senses, see the World Health Organization's public health updates https://www.who.int/emergencies/diseases/novel-coronavirus-2019.
Recent estimates from large cohort studies indicate that around 40 to 60 percent of covid-19 patients report olfactory dysfunction during acute infection, with rates varying by variant and vaccination status. The Omicron sub-lineages, which became dominant in multiple regions, were associated with somewhat lower rates of complete smell loss compared with earlier strains, yet partial smell reduction remains common. Clinicians use standardized smell tests, such as the Sniffin' Sticks or UPSIT, to quantify the severity of anosmia and track recovery. These data points help public health agencies model symptom prevalence and guide clinical guidance on when to test for covid-19 when sudden smell loss occurs. For analysis of symptom trends and variant impact, the Centers for Disease Control and Prevention provides updated surveillance https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html.
Why Losing Sense of Smell Covid Happens
Mechanism of Smell Loss in Covid-19
SARS-CoV-2 primarily affects smell by infecting sustentacular cells in the olfactory epithelium rather than directly destroying olfactory neurons, leading to temporary disruption of odor signal transmission. Inflammation and edema in the nasal lining, combined with changes in the olfactory cleft, can block odorant molecules from reaching receptors. Research published in peer-reviewed journals has shown that viral persistence or post-infectious immune activity may prolong smell dysfunction in a subset of patients. Understanding the cellular mechanism helps explain why many people recover their sense of smell over weeks to months, while some experience prolonged or delayed improvement. For a scientific perspective on viral mechanisms, the National Institutes of Health maintains research resources https://www.nih.gov/health-information/coronavirus-disease-covid-19.
Risk Factors and Duration
Factors associated with more severe or prolonged losing sense of smell covid include female sex, higher baseline symptom burden, and infection with certain variants, though individual immune responses vary widely. Most patients experience partial or full recovery within four weeks, but a notable minority report persistent olfactory dysfunction beyond three months, a condition often termed post-acute covid-19 olfactory dysfunction. Nasal corticosteroid sprays, olfactory training with essential oils, and structured smell-retraining protocols are commonly recommended by otolaryngologists to accelerate recovery. Clinical trials continue to evaluate therapies such as omega-3 supplements and platelet-rich plasma for refractory cases. For guidance on treatment options, the American Academy of Otolaryngology provides clinical resources https://www.entnet.org/.
Recovery Outlook and When to Seek Care
Typical Recovery Timeline
Recovery from losing sense of smell covid follows a variable trajectory, with many patients noticing improvement within the first two to four weeks after symptom onset. Structured olfactory training, involving repeated exposure to a set of distinct scents twice daily for several months, has shown modest benefits in multiple randomized trials. Patients who experience only partial smell loss tend to recover faster than those with complete anosmia, and younger age is often associated with better outcomes. Tracking daily smell scores using standardized